Foresite Capital Management IV as of June 30, 2018
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 17 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed (INSM) | 14.5 | $43M | 1.8M | 23.65 | |
| Biohaven Pharmaceutical Holding | 11.5 | $34M | 851k | 39.52 | |
| Immunomedics | 9.9 | $29M | 1.2M | 23.67 | |
| Myokardia | 9.6 | $28M | 566k | 49.65 | |
| Cymabay Therapeutics | 9.3 | $27M | 2.0M | 13.42 | |
| Optinose (OPTN) | 8.9 | $26M | 929k | 27.98 | |
| Rhythm Pharmaceuticals (RYTM) | 7.7 | $23M | 722k | 31.26 | |
| Arbutus Biopharma (ABUS) | 6.6 | $19M | 2.7M | 7.30 | |
| Ascendis Pharma A S (ASND) | 6.1 | $18M | 270k | 66.52 | |
| Alder Biopharmaceuticals | 6.1 | $18M | 1.1M | 15.80 | |
| Aclaris Therapeutics (ACRS) | 3.6 | $11M | 530k | 19.97 | |
| Alder Biopharmaceuticals Inc put | 1.9 | $5.5M | 350k | 15.80 | |
| Eidos Therapeutics | 1.7 | $5.0M | 245k | 20.34 | |
| Arcus Biosciences Incorporated (RCUS) | 1.2 | $3.6M | 295k | 12.24 | |
| Tricida | 0.8 | $2.2M | 75k | 29.91 | |
| Kiniksa Pharmaceuticals | 0.6 | $1.6M | 95k | 17.35 | |
| Uniqure Nv (QURE) | 0.1 | $403k | 11k | 37.84 |
